Morgan Stanley’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $599K | Buy |
21,113
+5,049
| +31% | +$143K | ﹤0.01% | 5379 |
|
2025
Q1 | $496K | Buy |
16,064
+2,288
| +17% | +$70.6K | ﹤0.01% | 5327 |
|
2024
Q4 | $457K | Buy |
13,776
+796
| +6% | +$26.4K | ﹤0.01% | 5455 |
|
2024
Q3 | $393K | Buy |
12,980
+5,744
| +79% | +$174K | ﹤0.01% | 5510 |
|
2024
Q2 | $204K | Sell |
7,236
-1,052
| -13% | -$29.7K | ﹤0.01% | 5665 |
|
2024
Q1 | $307K | Sell |
8,288
-12,490
| -60% | -$462K | ﹤0.01% | 5543 |
|
2023
Q4 | $854K | Buy |
20,778
+15,794
| +317% | +$649K | ﹤0.01% | 5376 |
|
2023
Q3 | $155K | Sell |
4,984
-1,104
| -18% | -$34.4K | ﹤0.01% | 5696 |
|
2023
Q2 | $244K | Sell |
6,088
-3,954
| -39% | -$159K | ﹤0.01% | 5555 |
|
2023
Q1 | $414K | Buy |
10,042
+4,907
| +96% | +$202K | ﹤0.01% | 5359 |
|
2022
Q4 | $234K | Buy |
5,135
+1,900
| +59% | +$86.5K | ﹤0.01% | 5601 |
|
2022
Q3 | $96K | Buy |
3,235
+2,044
| +172% | +$60.7K | ﹤0.01% | 6096 |
|
2022
Q2 | $25K | Sell |
1,191
-806
| -40% | -$16.9K | ﹤0.01% | 6903 |
|
2022
Q1 | $56K | Sell |
1,997
-3,675
| -65% | -$103K | ﹤0.01% | 6649 |
|
2021
Q4 | $167K | Buy |
5,672
+1,421
| +33% | +$41.8K | ﹤0.01% | 6156 |
|
2021
Q3 | $146K | Buy |
4,251
+3,856
| +976% | +$132K | ﹤0.01% | 6164 |
|
2021
Q2 | $15K | Buy |
+395
| New | +$15K | ﹤0.01% | 7107 |
|